Isothermal Titration Calorimetric Study of RNase-A Kinetics (cCMP rarr 3'-CMP) Involving End-Product Inhibition

Authors: Shawn D. Spencer1; Robert B. Raffa2

Source: Pharmaceutical Research, Volume 21, Number 9, September 2004 , pp. 1642-1647(6)

Publisher: Springer

Buy & download fulltext article:

OR

Price: $47.00 plus tax (Refund Policy)

Abstract:

Purpose. Isothermal titration calorimetry (ITC) and progress curve analysis was used to measure the enzyme kinetic parameters (KM and Kcat) of the hydrolysis of cCMP by RNase-A, a reaction that includes end-product competitive inhibition by 3'-CMP.

Methods. The heat generated from injection of 9-15 mul cCMP (20 mM) into bovine pancreatic RNase-A (600 nM) in 50 mM Na+ acetate buffer (pH 5.5; 37°C) was monitored for 1500-2000 s. Thermal power (dQ/dt), equal to (1) /DgrHapp × d(cCMP)/dt was recorded every 1 s. The end-product inhibition constant (Kp) and enthalpy of the inhibitor binding interaction was obtained from the saturation data of 60 sequential injections of 3'-CMP (1.2 mM) into 0.05 mM RNase-A. The data of the plot of -d[cCMP]/dt against [cCMP] were fitted to kinetic equations incorporating Kp to yield KM and Kcat.

Results. DgrHapp for each run was obtained by integration of the progress curve. The plot of -d[cCMP]/dt against [cCMP] yielded the kinetic parameters KM = 105.3 muM, 121.6 muM, and 131.3 muM; Kcat = 1.63 s-1, 1.56 s-1, and 1.71 s-1. The end-product bound with 1:1 stoichiometry and Kp = 53.2 muM.

Conclusions. The combination of progress curve analysis and ITC allowed rapid and facile measurement of the kinetic parameters for catalytic conversion of cCMP to 3'-CMP by RNase-A, a reaction complicated by end-product inhibition.

Keywords: calorimetry; end-product inhibition; enzyme kinetics; RNase

Document Type: Research article

DOI: http://dx.doi.org/10.1023/B:PHAM.0000041460.78128.0f

Affiliations: 1: Department of Pharmaceutical Sciences, School of Pharmacy, Temple University, Philadeplhia, Pennsylvania 19140, USA 2: Department of Pharmaceutical Sciences, School of Pharmacy, Temple University, Philadeplhia, Pennsylvania 19140, USA; Department of Pharmacology, School of Medicine, Temple University, Philadelphia, Pennsylvania 19140, USA. ( ), Email: robert.raffa@temple.edu

Publication date: 2004-09-01

Related content

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page